EPA:VETO - Euronext Paris - Matif - FR0004186856 - Common Stock - Currency: EUR
EPA:VETO (3/14/2025, 7:00:00 PM)
71.6
-0.4 (-0.56%)
The current stock price of VETO.PA is 71.6 EUR. In the past month the price decreased by -3.11%. In the past year, price decreased by -30.89%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LLY.DE | ELI LILLY & CO | 62.35 | 705.91B | ||
1LLY.MI | ELI LILLY & CO | 61.73 | 698.80B | ||
ZEG.DE | ASTRAZENECA PLC | 18.87 | 441.02B | ||
JNJ.DE | JOHNSON & JOHNSON | 16.29 | 359.55B | ||
NOV.DE | NOVO NORDISK A/S-B | 23.41 | 314.82B | ||
SAN.PA | SANOFI | 13.83 | 266.31B | ||
SNW.DE | SANOFI | 13.83 | 266.26B | ||
1SAN.MI | SANOFI | 13.83 | 266.26B | ||
6MK.DE | MERCK & CO. INC. | 12.22 | 216.73B | ||
1PFE.MI | PFIZER INC | 8.33 | 135.00B | ||
PFE.DE | PFIZER INC | 8.26 | 133.83B | ||
1BMY.MI | BRISTOL-MYERS SQUIBB CO | 55.11 | 117.44B |
Vétoquinol SA operates as a global animal health company. The company is headquartered in Lure, Bourgogne-Franche-Comte and currently employs 2,519 full-time employees. The company went IPO on 2006-11-16. The Company’s product portfolio is divided between livestock, such as cattle and pigs, and companion animals, including dogs and cats. Vetoquinol SA’s offering includes anti-infectives, such as Marbocyl; anti- pain inflammatories, which comprise Tolfedine, intended for dogs and cats, and Tolfine for livestock, and cardiovascular and nephrology treatment, such as Prilium, an oral daily administration formula for dogs, among others. The firm markets over 700 products, in such countries as France, Austria, Canada, Italy, Poland, Spain and the Netherlands, among others. The company trades its products throughout Europe, North America, Africa, the Middle East and Pacific Asia. In April 2014, it acquired Bioniche's animal health business.
VETOQUINOL SA
Sainte-Anne 34 rue du Chene, Bp 189, Lure Cedex
Lure BOURGOGNE-FRANCHE-COMTE FR
Employees: 2519
Company Website: https://www.vetoquinol.com/fr
Investor Relations: https://www.vetoquinol.com/en/investors
Phone: 33384625555
The current stock price of VETO.PA is 71.6 EUR. The price decreased by -0.56% in the last trading session.
The exchange symbol of VETOQUINOL SA is VETO and it is listed on the Euronext Paris - Matif exchange.
VETO.PA stock is listed on the Euronext Paris - Matif exchange.
11 analysts have analysed VETO.PA and the average price target is 96.08 EUR. This implies a price increase of 34.2% is expected in the next year compared to the current price of 71.6. Check the VETOQUINOL SA stock analysts ratings, price target forecast and up-and down grades for more detailed information.
VETOQUINOL SA (VETO.PA) has a market capitalization of 850.61M EUR. This makes VETO.PA a Small Cap stock.
VETOQUINOL SA (VETO.PA) currently has 2519 employees.
VETOQUINOL SA (VETO.PA) has a resistance level at 71.87. Check the full technical report for a detailed analysis of VETO.PA support and resistance levels.
The Revenue of VETOQUINOL SA (VETO.PA) is expected to grow by 1.1% in the next year. Check the estimates tab for more information on the VETO.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
VETOQUINOL SA (VETO.PA) has a dividend yield of 1.18%. The yearly dividend amount is currently 0.8. Check the full fundamental report for a detailed analysis of VETO.PA dividend history, reliability and sustainability.
VETOQUINOL SA (VETO.PA) will report earnings on 2025-03-20, after the market close.
The PE ratio for VETOQUINOL SA (VETO.PA) is 17.99. This is based on the reported non-GAAP earnings per share of 3.98 and the current share price of 71.6 EUR. Check the full fundamental report for a full analysis of the valuation metrics for VETO.PA.
ChartMill assigns a fundamental rating of 6 / 10 to VETO.PA. VETO.PA has an excellent financial health rating, but there are some minor concerns on its profitability.
Over the last trailing twelve months VETO.PA reported a non-GAAP Earnings per Share(EPS) of 3.98. The EPS decreased by -19.87% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 8.77% | ||
ROA | 6.67% | ||
ROE | 8.68% | ||
Debt/Equity | 0.02 |
ChartMill assigns a Buy % Consensus number of 76% to VETO.PA. The Buy consensus is the average rating of analysts ratings from 11 analysts.
For the next year, analysts expect an EPS growth of 7.56% and a revenue growth 1.1% for VETO.PA